Revia

Revia is a brand name of naltrexone, approved by the FDA in the following formulation(s):

REVIA (naltrexone hydrochloride - tablet; oral)

• 
  Manufacturer: DURAMED
  
  Approval date: November 20, 1984
  
  Strength(s): 50MG ^[RLD][AB]

Has a generic version of Revia been approved?

Yes. The following products are equivalent to Revia:

naltrexone hydrochloride tablet; oral

• 
  Manufacturer: ACCORD HLTHCARE
  
  Approval date: August 17, 2011
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: BARR
  
  Approval date: May 8, 1998
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: ELITE LABS
  
  Approval date: May 26, 1999
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: MALLINCKRODT
  
  Approval date: March 22, 2002
  
  Strength(s): 50MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: March 8, 2000
  
  Strength(s): 50MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Revia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Revia.

See also...

• Revia Consumer Information (Wolters Kluwer)
• ReVia Consumer Information (Cerner Multum)
• Revia Advanced Consumer Information (Micromedex)
• Naltrexone Consumer Information (Wolters Kluwer)
• Naltrexone Consumer Information (Cerner Multum)
• Naltrexone injection Consumer Information (Cerner Multum)
• Naltrexone Advanced Consumer Information (Micromedex)
• Naltrexone Intramuscular Advanced Consumer Information (Micromedex)
• Naltrexone AHFS DI Monographs (ASHP)